Difference between revisions of "Breast cancer BRCA1 & BRCA2 genetic testing"
Jump to navigation
Jump to search
m (added link) |
Warner-admin (talk | contribs) m (Warner-admin moved page Breast cancer BRCA1/BRCA2 genetic testing to Breast cancer BRCA1 & BRCA2 genetic testing without leaving a redirect: Reserved character) |
||
(10 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | '''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].''' | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> |
=Criteria for BRCA1/BRCA2 genetic testing= | =Criteria for BRCA1/BRCA2 genetic testing= | ||
Line 19: | Line 19: | ||
==References== | ==References== | ||
<references /> | <references /> | ||
+ | |||
+ | [[Category:Breast cancer pages]] | ||
+ | [[Category:Disease-specific pages]] | ||
+ | [[Category:General reference pages]] |
Latest revision as of 16:38, 23 November 2019
Criteria for BRCA1/BRCA2 genetic testing
This is from a clinical trial protocol and is similar to, but not identical to, the NCCN breast cancer familiar risk assessment guidelines.[1] Additional resources can be found at the links below.[2][3]
- Breast cancer diagnosed ≤45 years old
- Diagnosed at age ≤50 years old with:
- first, second, or third-degree blood relative with breast cancer diagnosis ≤50 years old
- and/or epithelial ovarian or fallopian peritoneal cancer at any age
- Diagnosed at age <60 years old with a triple negative breast cancer
- Two breast primaries--that is, bilateral disease or two or more clearly separate ipsilateral primary tumors--when first breast cancer diagnosis occurred prior to age 50
- Personal history of epithelial ovarian, fallopian tube, or primary peritoneal cancer
- Diagnosed at any age with ≥2 first, second, or third-degree relatives with breast and/or epithelial ovarian, fallopian tube, or primary peritoneal cancer at any age
- First or second-degree relative of anybody known to carry a harmful BRCA1 or BRCA2 mutation
- Ashkenazi Jewish descent
- Male breast cancer
- First, second, or third-degree male relative with breast cancer